InsiderClue
← All stocks

Vera Therapeutics, Inc.

VERA Scheduled selling only
CIK 0001831828 #1966 in the set updated 21 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$1.33M
$0.00 on a plan · $1.33M straight out of an exercise
Sold at will
$0.00
0 of 2 sales
Net
−$1.33M
$0.00 against sales at will

By person

12 insiders · 3 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Fordyce Marshall
PRESIDENT AND CEO
—
$1.33M (2) scheduled
−$1.33M
235,244
0.3264%
$8.70M
+37.7%
ENRIGHT PATRICK G
Director
—
—
—
3,602,475
5.00%
$133.29M
+7.6%
SEIDENBERG BETH C
Director
—
—
—
131,553
0.1826%
$4.87M
−10.2%
Grant Sean
CHIEF FINANCIAL OFFICER
—
—
—
114,181
0.1584%
$4.22M
+69.8%
Young Joseph R
SVP, FINANCE, CHIEF ACCT OFFCR
—
—
—
80,754
0.1121%
$2.99M
+52.0%
Skelton Laurence Matthew
Chief Commercial Officer
—
—
—
64,218
0.0891%
$2.38M
+40.2%
Brenner Robert
Chief Medical Officer
—
—
—
50,947
0.0707%
$1.89M
+4,153%
Carter Jason S
Chief Legal Officer
—
—
—
49,136
0.0682%
$1.82M
—
JOHNSON DAVID LEE
Chief Operating Officer
—
—
—
45,727
0.0635%
$1.69M
+3,152%
Turner William D.
Chief Regulatory Officer
—
—
—
45,313
0.0629%
$1.68M
—
Boman Nancy Lee
Chief Regulatory Officer
—
—
—
44,987
0.0624%
$1.66M
—
Wright-Mitchell Jane
Chief Legal Officer
—
—
—
42,403
0.0588%
$1.57M
—

Individual transactions

3
Insider
Date
Role
Action
Shares
Price
Amount
Fordyce Marshall
15 Sep 2026
PRESIDENT AND CEO
Sold after exercise
18,500
$37.00
$684.50K
Young Joseph R
11 Sep 2026
SVP, FINANCE, CHIEF ACCT OFFCR
Exercised, kept
5,000
$3.94
$19.70K
Fordyce Marshall
2 Sep 2026
PRESIDENT AND CEO
Sold after exercise
18,500
$35.12
$649.64K

What was left out

Form 4 filings counted 3
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 2
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 42,000
History held since 17 May 2021